Superdisintegrants Market Size, Share, and Forecast by 2031
Superdisintegrants Market: Strategic Insights
Superdisintegrants Market
-
CAGR (2023 - 2031)7.60% -
Market Size 2023
US$ 0.50 Billion -
Market Size 2031
US$ 0.89 Billion
Market Dynamics
GROWTH DRIVERS
- An increase in Demand for Superdisintegrants leads to the Growing Adoption of Orally Disintegrating Drugs
FUTURE TRENDS
- The Increasing Acceptability of Generic Drugs
OPPORTUNITIES
- Significant Research and Development to Develop Pharmaceutical Products
Key Players
- Ashland
- Asahi Kasei Corporation
- Avantor Inc
- BASF SE
- Corel Pharma Chem
- Dow DuPont Inc
- DFE Pharma
- JRS Pharma
- MERCK KGAA
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Synthetic Superdisintegrants
- Natural Superdisintegrants
- Other Superdisintegrants
Formulation
- Tablets
- Capsules
Therapeutic Area
- Neurological Diseases
- Gastrointestinal Diseases
- Oncology
- Inflammatory Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Other Diseases